No action is without its side effects: adverse drug reactions and missed doses of anti-tuberculosis therapy, a scoping review.

Eleanor Grace DixonShaista RasoolBrian OtaaloAshmika MoteeJames W DearDerek SloanHelen R Stagg

Published in: British journal of clinical pharmacology (2023)

There is extensive evidence that ADRs are a key driver for missed doses of anti-TB treatment. Some papers examined specific ADRs and none evaluated the patterns of missed doses due to ADRs, demonstrating a knowledge deficit. Knowing why doses both are and are not missed is essential in providing targeted interventions to improve treatment outcomes.

Keyphrases

adverse drug
mycobacterium tuberculosis
emergency department
physical activity
stem cells
bone marrow
pulmonary tuberculosis
combination therapy
hiv infected